Nordic Breast Cancer Arena
ESMO Breast 2026: Optimizing Immunotherapy in Early TNBC
/ Giampaolo Bianchini
Breast cancer
- Meet the Experts
- 2025
International Breast Cancer Round Table: Bringing Global Insights to Nordic Practice
- / BestPractice Nordic
TP53 Mutations as a Predictive Biomarker in High-Risk Breast Cancer
/ Mari Eskild Rasmussen
AI-Based Extraction of Retrospective Pathology Data for Breast Cancer Research
/ Agnar Martin Bjørnstad
T-DXd in Patients with High-Risk HER2-Positive Early Breast Cancer – Are We Ready to Change Practice?
/ Henrik Lindman / Jan Andreasen








